Effects and Safety of Different Dose of Bambuterol on Chinese COPD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
COPD
Interventions
DRUG

bambuterol

Patients will be randomized allocated to receive three treatment sequences I, II and III, every treatment period is separated by a washout period of 7 days.

DRUG

Placebo

Trial Locations (3)

510000

Guangzhou First Municipal People's Hospital, Guangzhou

Nanfang Hospital of Southern Medical University, Guangzhou

510120

Guangzhou Institution of Respiratory Disease (GIRD), The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Guangzhou First People's Hospital

OTHER

lead

The First Affiliated Hospital of Guangzhou Medical University

OTHER

NCT01796730 - Effects and Safety of Different Dose of Bambuterol on Chinese COPD Patients | Biotech Hunter | Biotech Hunter